Single dose pharmacokinetic study of lithium in Taiwanese/Chinese bipolar patients

References

• Olatawara M O. The effects of psychotropic drugs in different populations. Bulletin of the World Health Organization 1978; 56: 519–523
   Google Scholar
• Yamamoto J, Fung D, Lo S, Reece S. Psychopharmacology for Asian Americans and Pacific Islanders. Psychopharmacology Bulletin 1979; 15: 29–31
   Google Scholar
• Yamashita I, Asano Y. Tricyclic antidepressants: therapeutic plasma level. Psychopharmacology Bulletin 1979; 15: 40–41
   Google Scholar
• Takahashi R. Lithium treatment in affective disorders: therapeutic plasma level. Psychopharmacology Bulletin 1979; 15: 32–35
   Google Scholar
• Lin K M, Poland R E. Pharmacotherapy of Asian patients. Psychiatry Annuals 1980; 19: 659–663
   Google Scholar
• Lin K M, Finder E. Neuroleptic dosage in Asians. American Journal of Psychiatry 1983; 140: 490–491
   PubMed Web of Science ®Google Scholar
• Potkin S G, Shen Y, Pardes H, et al. Haloperidol concentrations elevated in Chinese patients. Psychiatry Research 1984; 12: 167–172
   PubMedGoogle Scholar
• Chang W H, Chen T Y, Lee C F, Hu W H, Yeh E K. Low plasma reduced haloperidol/haloperidol ratios in Chinese patients. Biological Psychiatry 1987; 22: 1406–1408
   PubMed Web of Science ®Google Scholar
• Lin K M, Poland R E, Lesser I M. Ethnicity and psychopharmacology. Culture, Medicine and Psychiatry 1986; 10: 151–165
   Google Scholar
• Wood A J, Zhou H H. Ethnic differences in drug disposition and responsiveness. Clinical Pharmacokinetics 1991; 1–24
   Google Scholar
• Mendoza R, Smith M W, Poland R E, Lin K M, Strickland T L. Ethnic psychopharmacology: the Hispanic and native American perspective. Psychopharmacology Bulletin 1991; 27: 449–461
   PubMed Web of Science ®Google Scholar
• Strickland T L, Ranganath V, Lin K M, Poland R E, Mendoza R, Smith M W. Psychopharmacologic considerations in the treatment of black American populations. Psychopharmacology Bulletin 1991; 27: 441–448
   PubMed Web of Science ®Google Scholar
• Lin K M, Poland R E, Smith M W, Strickland T L, Mendoza R. Pharmacokinetic and other related factors affecting psychotropic responses in Asians. Psychopharmacology Bulletin 1991; 27: 427–439
   PubMedGoogle Scholar
• Sedman A J, Wagner J G. Cstrip, a FORTRAN IV computer program for obtaining initial polyexponential parameter estimates. Journal of Pharmacological Science 1976; 65: 1006–1010
   PubMed Web of Science ®Google Scholar
• Meltzler C M, Weiner D L. PCNONLIN user's guide. KY Statistical Consultants, Lexington 1989
   Google Scholar
• Gibaldi M, Pemer D. Pharmacokinetics. 2nd ed. Marcel Dekker, New York 1982
   Google Scholar
• Takahashi R, Nakane Y, Akiyama A. Lithium treatment in affective disorders from viewpoint of transcultural psychopharmacology: therapeutic plasma level. Folia psychiatrica et Neurologica Japonica 1979; 33: 501–509
   Google Scholar
• Chang S S, Pandey G N, Zhang M Y, Ku N F, Davis J M. ‘Racial differences in plasma and RBC lithium levels’. Paper presented at the annual meeting of American Psychiatric Association. Continuing Medical Education Syllabus and Scientific Proceedings 1984; 11: 239–240
   Google Scholar
• Chang S S, Pandey G N, Yang Y Y, Yeh E K, Davis J M. ‘Lithium pharmacokinetics:Interracial comparison’. Paper presented at the 138th Annual Meeting of the American Psychiatric Association, Dallas, Texas, May, 1985
   Google Scholar
• Yang Y Y. Prophylactic efficacy of lithium and its effective plasma levels in Chinese bipolar patients. Acta Psychiatrica Scandinavica 1985; 71: 171–175
   PubMed Web of Science ®Google Scholar
• Yang Y Y, Yeh E K, Chang S S, Deng H C, Lee C F. Maintenance lithium levels could be lowered: based on Taiwanese and Danish studies. Journal of the Formosan Medical Association 1991; 90: 509–513
   Google Scholar
• Tseng H Y, Chen C C, Wen J K. The single dose bioavailability of different lithium carbonate products. Journal of the Formosan Medical Association 1987; 86: 543–548
   Google Scholar
• Caldwell H C, Westlake W J, Connor S M, James N H. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man. Journal of Clinical Pharmacology 1971; 11: 349–356
   Web of Science ®Google Scholar
• Altamura A C, Gomeni R, Sacchetti E, Smeraldi E. Plasma and intracellular kinetics of lithium after oral administration of various lithium salts. European Journal of Clinical Phatmacology 1977; 12: 59–63
   Google Scholar
• Amdisen A. Serum level monitoring and clinical pharmacolinetics of lithium. Clinical Pharmacokinerics 1977; 2: 13–92
   Google Scholar
• Mason R W, McQueen E G, Kearg P J, James N M. Pharmacokinetics of lithium: elimination half-time, renal clearance and apparent volume of distribution of schizophrenia. Clinical Pharmacokinetics 1978; 3: 241–246
   PubMed Web of Science ®Google Scholar
• Nielsen-Kudsk Amdisen A. Analysis of the pharmacokinetics of lithium in man. European Journal of Clinical Pharmacology 1979; 16: 271–277
   Web of Science ®Google Scholar